Welshare Health has emerged as a pioneering force in the DeSci (Decentralized Science) arena, announcing the development of an innovative decentralized application designed to empower individuals in contributing to AI-enhanced medical research. This app, built on Base, aims to give patients increased control over their health data while allowing them to tailor their participation in medical studies. As per the developers’ claims, the Welshare Health application could significantly change the landscape of how medical research is conducted and how healthcare services are provided.
In May 2024, Welshare Health launched its first closed beta of the decentralized application. Leveraging DeSci principles, it integrates the capabilities of AI-driven medical research with Web3 technologies. This burgeoning field utilizes blockchain and decentralized frameworks to democratize scientific inquiry. Currently in closed beta, interested users can join an exclusive waiting list for early access.
Welshare Health identifies that conventional medical research is often sluggish and struggles with major limitations, chiefly the restricted access to diverse datasets. It is reported that medical research organizations invest up to $600 billion annually on data silos due to inefficient clinical trial recruitment processes and insufficient insights into patient behaviors. In such scenarios, patients have a minimal say over how their health data is utilized, resulting in little advantage from their involvement in research.
The Welshare Health platform effectively removes intermediaries, linking patients directly with medical research endeavors. This facilitates patient agency over their health data and aids research organizations in addressing the significant $600 billion health data challenge. By utilizing Web3 innovations like blockchain-based smart contracts, the platform ensures secure handling of data processing, ownership, and revenue generation while preserving user privacy.
The app’s primary focus will initially be on diabetes research, connecting users to relevant research activities via partnerships with diabetes advocacy organizations. Nonetheless, the developers encourage all individuals, regardless of diabetes status, to register and complete a medical questionnaire; this information will enhance the app’s database as it expands into additional therapeutic domains.
The Welshare Health team recognizes the numerous challenges faced by individuals dealing with type 1 diabetes (T1D), including the inadequacies of non-personalized automated insulin delivery (AID) systems. These systems often fail to adapt to the diverse physiological and lifestyle factors that affect blood glucose levels, leading to frustration, anxiety, and an additional burden of managing the condition.
To address these challenges, Welshare Health aims to integrate AI to craft highly personalized algorithms that could transform AID technologies. These algorithms would customize insulin delivery, employ predictive analytics, utilize adaptive learning, and incorporate various components from the broader digital health ecosystem such as wearables.
The Welshare Health application merges DeSci with AI functionalities, aiming to enhance patients’ lives by providing them greater command over their health issues. Within this evolving ecosystem, users become active contributors to medical research, transitioning from being mere data contributors to engaged participants. Utilizing smart contracts and decentralized governance systems, the app encourages responsible and ethical data sharing while ensuring an equitable distribution of rewards.
About Welshare Health
With a robust network spanning the pharmaceutical and Web3 worlds, Welshare Health unites traditional healthcare knowledge with innovative decentralized technology to create a distinct application that links individuals to the future of medical research. The AI-driven insights offered by the app empower users to make well-informed health choices, promoting proactive engagement in preventative care and disease management.
The Welshare Health team is comprised of healthcare professionals with over 10 years of experience from premier pharmaceutical and hospital institutions, such as Sanofi and Charité. The team also includes blockchain specialists, mobile app developers, business development and marketing advisors, as well as technical and patient community leaders. According to the project’s whitepaper, they collectively envision “a world where everyone can actively participate in advancing medical knowledge and enhancing healthcare outcomes.”
To discover more about Welshare Health and keep up with its latest updates, visit: Website | X (Twitter) | Telegram | Discord
Dutch
English
French
German
Greek
Italian
Portuguese
Russian
Spanish